申请人:Imperial Chemical Industries Limited
公开号:US04307111A1
公开(公告)日:1981-12-22
Triphenylalkene derivatives of the formula: ##STR1## wherein R.sup.1 is alkenyl, cycloalkenyl, cycloalkenylalkyl, halogenoalkenyl, hydroxyalkyl, dihydroxyalkyl, hydroxycycloalkyl, dihydroxycycloalkyl, hydroxycycloalkylalkyl, epoxyalkyl, alkoxyalkyl or alkylthioalkyl each of up to 10 carbon atoms, wherein R.sup.2 is alkyl of up to 6 carbon atoms, halogen or nitro and wherein ring A may optionally bear a halogen substituent or an alkoxy substituent of up to 4 carbon atoms. These compounds possess antioestrogenic activity and are useful in the treatment of anovulatory infertility and of breast tumours. Representative of the compounds is 1-p-allyloxyphenyl-trans-1,2-diphenylbut-2-ene. There are also disclosed processes for the manufacture of the compounds and pharmaceutical compositions containing them.
以下是中文翻译:
三苯基烯衍生物的化学式为:##STR1## 其中R.sup.1是烯基,环烯基,环烯基烷基,卤代烯基,羟基烷基,二羟基烷基,羟基环烷基,二羟基环烷基,羟基环烷基烷基,环氧烷基,烷氧基烷基或烷硫基烷基,每个基团中碳原子数不超过10个,其中R.sup.2是碳原子数不超过6个的烷基,卤素或硝基,环A可以选择性地带有最多4个碳原子的卤素取代基或烷氧基取代基。这些化合物具有抗雌激素活性,可用于治疗无排卵性不孕症和乳腺肿瘤。该化合物的代表是1-p-烯丙氧基苯基-反-1,2-二苯基丁-2-烯。还公开了制备该化合物的过程和含有它们的制药组合物。